Frequency Exchange Corp. announced that its wholly-owned subsidiary, FREmedica Technologies Inc. has signed its first White Label Agreement. The FREmedica bioenergetic frequency delivery system will be used to optimize and enhance products produced by Beleaf Pharma, a global company at the forefront of developing plant-based medicinal products based on ancient remedies.

The contracting of FREmedica as an exclusive supplier to Beleaf Pharma is the culmination of an investment of countless hours of development and hundreds of thousands of dollars over the past year alone. FREmedica offers the only patented bioenergetic technology platform designed to capture and deliver frequencies to a wearable device through Firmware and mobile App over the internet with interconnectivity to device. The platform can be used with a library of frequencies developed in house or developed by third parties for White Label applications.

This high-level partnership will generate global awareness and greatly accelerate growth in the White Label market. Beleaf's opening order will be valued at $500,000 and they will take delivery of the 1st 250 units by the end of August 2023, too be used for trials in Israel, with a 1,000-unit order to follow once trials are complete. The remaining 3,750 units to be delivered 6 months after the 1,000-unit order has been delivered.

This will give Beleaf the required time to trial their products in the form of frequencies in combination with their products using technology.